The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
The global Anti-Ageing Drugs market was valued at US$ 82060 million in 2023 and is anticipated to reach US$ 140690 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Ageing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Ageing Drugs.
Report Scope
The Anti-Ageing Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Ageing Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Ageing Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Nu Skin
- BIOTIME
- Elysium Health
- La Roche-Posay
- DermaFix
Segment by Type
- Hormonal Therapy
- Antioxidants
- Enzymes
- Stem Cells
- Others
Segment by Application
- Skin
- Hair
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Ageing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Ageing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Anti-Ageing Drugs Market Overview
1.1 Product Overview and Scope of Anti-Ageing Drugs
1.2 Anti-Ageing Drugs Segment by Type
1.2.1 Global Anti-Ageing Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Hormonal Therapy
1.2.3 Antioxidants
1.2.4 Enzymes
1.2.5 Stem Cells
1.2.6 Others
1.3 Anti-Ageing Drugs Segment by Application
1.3.1 Global Anti-Ageing Drugs Market Value by Application: (2024-2030)
1.3.2 Skin
1.3.3 Hair
1.3.4 Others
1.4 Global Anti-Ageing Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Ageing Drugs Revenue 2019-2030
1.4.2 Global Anti-Ageing Drugs Sales 2019-2030
1.4.3 Global Anti-Ageing Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Ageing Drugs Market Competition by Manufacturers
2.1 Global Anti-Ageing Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Ageing Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Ageing Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Ageing Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Ageing Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Ageing Drugs, Product Type & Application
2.7 Anti-Ageing Drugs Market Competitive Situation and Trends
2.7.1 Anti-Ageing Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Ageing Drugs Players Market Share by Revenue
2.7.3 Global Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Ageing Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Ageing Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Ageing Drugs Global Anti-Ageing Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-Ageing Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-Ageing Drugs Sales by Region: 2025-2030
3.3 Global Anti-Ageing Drugs Global Anti-Ageing Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-Ageing Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-Ageing Drugs Revenue by Region: 2025-2030
3.4 North America Anti-Ageing Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Ageing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Ageing Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-Ageing Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Ageing Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Ageing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Ageing Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-Ageing Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Ageing Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Ageing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Ageing Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Ageing Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Ageing Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Ageing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Ageing Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-Ageing Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Ageing Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Ageing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Ageing Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Ageing Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Ageing Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-Ageing Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-Ageing Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-Ageing Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-Ageing Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-Ageing Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-Ageing Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-Ageing Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Ageing Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Ageing Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-Ageing Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-Ageing Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-Ageing Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-Ageing Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-Ageing Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-Ageing Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-Ageing Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Ageing Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nu Skin
6.1.1 Nu Skin Corporation Information
6.1.2 Nu Skin Description and Business Overview
6.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nu Skin Anti-Ageing Drugs Product Portfolio
6.1.5 Nu Skin Recent Developments/Updates
6.2 BIOTIME
6.2.1 BIOTIME Corporation Information
6.2.2 BIOTIME Description and Business Overview
6.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BIOTIME Anti-Ageing Drugs Product Portfolio
6.2.5 BIOTIME Recent Developments/Updates
6.3 Elysium Health
6.3.1 Elysium Health Corporation Information
6.3.2 Elysium Health Description and Business Overview
6.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elysium Health Anti-Ageing Drugs Product Portfolio
6.3.5 Elysium Health Recent Developments/Updates
6.4 La Roche-Posay
6.4.1 La Roche-Posay Corporation Information
6.4.2 La Roche-Posay Description and Business Overview
6.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 La Roche-Posay Anti-Ageing Drugs Product Portfolio
6.4.5 La Roche-Posay Recent Developments/Updates
6.5 DermaFix
6.5.1 DermaFix Corporation Information
6.5.2 DermaFix Description and Business Overview
6.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DermaFix Anti-Ageing Drugs Product Portfolio
6.5.5 DermaFix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Ageing Drugs Industry Chain Analysis
7.2 Anti-Ageing Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Ageing Drugs Production Mode & Process
7.4 Anti-Ageing Drugs Sales and Marketing
7.4.1 Anti-Ageing Drugs Sales Channels
7.4.2 Anti-Ageing Drugs Distributors
7.5 Anti-Ageing Drugs Customers
8 Anti-Ageing Drugs Market Dynamics
8.1 Anti-Ageing Drugs Industry Trends
8.2 Anti-Ageing Drugs Market Drivers
8.3 Anti-Ageing Drugs Market Challenges
8.4 Anti-Ageing Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
